SCHEMBL27093613

SCHEMBL27093613

C[C@H]1CCCCN1c1ccc(N)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GFER P55789 1/20 0.47
▸ SMPD3 Q9NY59 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CHRM4 P08173 7/20 0.44
▸ JAK3 P52333 1/20 0.44
▸ HTT P42858 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NCOA3 Q9Y6Q9 1/20 0.42
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PDPK1 O15530 1/20 0.40
▸ TGFBR1 P36897 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27099909 1.00 GFER (0.47) GFERSMPD3ALDH1A1MEN1HPGD
SCHEMBL26633305 0.95 SMPD3 (0.50) GFERSMPD3ALDH1A1MEN1HPGD
SCHEMBL26633302 0.95 SMPD3 (0.50) GFERSMPD3ALDH1A1MEN1HPGD
SCHEMBL26633307 0.95 SMPD3 (0.50) GFERSMPD3ALDH1A1MEN1HPGD
SCHEMBL24092755 0.79 ALDH1A1 (0.45) GFERSMPD3ALDH1A1MEN1HPGD
SCHEMBL26739781 0.79 CHRM4 (0.45) SMPD3CHRM4JAK3HTTLMNA
SCHEMBL16255265 0.78 CNR2 (0.50) ALDH1A1CHRM4LMNASMN1; SMN2KDM4E
SCHEMBL16254909 0.78 ALDH1A1 (0.46) SMPD3ALDH1A1CHRM4JAK3HTT
SCHEMBL27583894 0.78 GRM5 (0.37) GFERALDH1A1KMT2AMAPT
SCHEMBL17696407 0.78 SMPD3 (0.45) SMPD3CHRM4JAK3HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323350-A1 ISOINDOLINONE COMPOUNDS Monte Rosa Therapeutics AG (CH) 2024-02-21 — — EP disclosed
Send feedback